Irritable Bowel Syndrome
9 drugs6,253 FAERS reportsMedDRA PT
GET
/api/v1/reaction/irritable-bowel-syndromeReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D043183
A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
Source: U.S. National Library of Medicine — MeSH (Irritable Bowel Syndrome)
Drugs reporting Irritable Bowel Syndrome (9)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Triclosan17435%
- 2Desogestrel76819%
- 3Chlorhexidine1,58517%
- 4Gepotidacin114%
- 5Thioridazine59.4%
- 6Difenoxin27.7%
- 7Isopropyl Alcohol1,6815.0%
- 8Isotretinoin2,0154.2%
- 9Alosetron222.4%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
Literature
Recent PubMed references pinned to Irritable Bowel Syndrome as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Repeated dosing of myrrh, chamomile extract, and coffee charcoal reveals potential health-beneficial effects in patients with irritable bowel syndrome in the M-SHIME simulator.PloS one · 2026 · Wonnemann M, Lipowicz B, Duysburgh C, et al.PMID 42201886DOI 10.1371/journal.pone.0348791
- Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study.Nutrients · 2026 · Lambiase C, Cancelli L, Tedeschi R, et al.PMID 42197028DOI 10.3390/nu18101569
- Cardiometabolic Burden of Irritable Bowel Syndrome: A Case-Control Analysis of Metabolic Syndrome Clustering.Journal of epidemiology and global health · 2026 · Abdelaziz MN, Abdallah O, Bshar AM, et al.PMID 42185575DOI 10.1007/s44197-026-00584-1
- Bifidobacterium breve Promotes the Pathogenesis of IBS by Downregulating the Expression of Ferroptosis-Related Molecule ERBB1: A Mendelian Randomization Mediation Analysis.Human mutation · 2026 · Mo L, Wu Y, Zhou Y, et al.PMID 42170302DOI 10.1155/humu/6705631
- Efficacy of Internet-Based Self-Help Interventions for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2026 · Xu X, Liu T, Wang F, et al.PMID 42166786DOI 10.2196/87216
- High-resolution metagenomic characterization of gut microbiota composition and functional pathways in irritable bowel syndrome.Scientific reports · 2026 · Ranasinghe PD, Barazanji N, Bednarska O, et al.PMID 42162115DOI 10.1038/s41598-026-52163-w
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.